Skip to main content

Table 1 Study design

From: The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial

Groups Vaccination schedule
1st vaccination (month 1) 2nd vaccination (month 2) 3rd vaccination
Group 1 JE vaccination JE vaccination Yellow fever vaccination 1 month after second JE vaccine
Group 2 JE vaccination JE vaccination Yellow fever vaccination 4 months after second JE vaccine
Group 3 JE vaccination JE vaccination Yellow fever vaccination 9 months after second JE vaccine
Group 4 Yellow fever vaccination No vaccination No vaccination
  1. JE, Japanese encephalitis.